AstraZeneca Pharma India Limited (NSE:ASTRAZEN)

Market Cap	150.76B -33.9%
Revenue (ttm)	24.32B +31.1%
Net Income	1.70B -7.5%
EPS	67.85 -7.5%
Shares Out	n/a
PE Ratio	88.88
Forward PE	n/a
Dividend	36.00 (0.60%)
Ex-Dividend Date	Jul 31, 2026

Volume	11,471
Open	6,153.50
Previous Close	6,186.00
Day's Range	5,986.00 - 6,172.00
52-Week Range	5,986.00 - 9,849.50
Beta	0.22
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About AstraZeneca Pharma India

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. A...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1979
• Employees: 600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ASTRAZEN

Financial Performance

In fiscal year 2026, AstraZeneca Pharma India's revenue was 22.76 billion, an increase of 32.59% compared to the previous year's 17.16 billion. Earnings were 1.88 billion, an increase of 62.02%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error